Literature DB >> 14531488

Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia.

David S Knopman1, Bradley F Boeve, Ronald C Petersen.   

Abstract

Loss of cognitive function in the elderly population is a common condition encountered in general medical practice. Diagnostic criteria and approaches have become more refined and explicit in the past several years. Precise diagnosis is feasible clinically. In this article, the precursor state and major subtypes of dementia are considered. Mild cognitive impairment is the term given to patients with cognitive impairment that is detectable by clinical criteria but does not produce impairment in daily functioning. When daily functioning is impaired as a result of cognitive decline, dementia is the appropriate syndromic label. Specific causes of dementia tend to have distinctive clinical presentations: the anterograde amnesic syndrome of Alzheimer disease; the syndrome of dementia with cerebrovascular disease; the syndrome of Lewy body dementia with its distinctive constellation of extrapyramidal features, disordered arousal, and dementia; the behavioral-cognitive syndrome of frontotemporal dementia; the primary progressive aphasias; and the rapidly progressive dementias. Because dementia syndromes have distinctive natural histories, precise diagnosis leads to a better understanding of prognosis. As new treatments become available for Alzheimer disease, the most common of the dementias, accurate diagnosis allows the appropriate patients to receive treatment.

Entities:  

Mesh:

Year:  2003        PMID: 14531488     DOI: 10.4065/78.10.1290

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  55 in total

1.  Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study.

Authors:  Silvia Mejia-Arango; Luis Miguel Gutierrez
Journal:  J Aging Health       Date:  2011-10

2.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

3.  Methods to identify dementia in the electronic health record: Comparing cognitive test scores with dementia algorithms.

Authors:  Barbara N Harding; James S Floyd; Jeffrey F Scherrer; Joanne Salas; John E Morley; Susan A Farr; Sascha Dublin
Journal:  Healthc (Amst)       Date:  2020-05-22

4.  Potential beneficial effects of low molecular weight heparin on cognitive impairment in elderly patients on haemodialysis.

Authors:  Milenka Sain; Vedran Kovacic; Josipa Radic; Dragan Ljutic; Ivo Jelicic
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

Review 5.  Cognitive assessment for clinicians.

Authors:  C M Kipps; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

6.  Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.

Authors:  G G Neznamov; E S Teleshova
Journal:  Neurosci Behav Physiol       Date:  2009-03

7.  Biomarkers of basic activities of daily living in Alzheimer's disease.

Authors:  James R Hall; Leigh A Johnson; Robert C Barber; Hoa T Vo; A Scott Winter; Sid E O'Bryant
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  Modifying roles of glutathione S-transferase polymorphisms on the association between cumulative lead exposure and cognitive function.

Authors:  Ki-Do Eum; Florence T Wang; Joel Schwartz; Craig P Hersh; Karl Kelsey; Robert O Wright; Avron Spiro; David Sparrow; Howard Hu; Marc G Weisskopf
Journal:  Neurotoxicology       Date:  2013-08-16       Impact factor: 4.294

9.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Authors:  Nigel J Cairns; Eileen H Bigio; Ian R A Mackenzie; Manuela Neumann; Virginia M-Y Lee; Kimmo J Hatanpaa; Charles L White; Julie A Schneider; Lea Tenenholz Grinberg; Glenda Halliday; Charles Duyckaerts; James S Lowe; Ida E Holm; Markus Tolnay; Koichi Okamoto; Hideaki Yokoo; Shigeo Murayama; John Woulfe; David G Munoz; Dennis W Dickson; Paul G Ince; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2007-06-20       Impact factor: 17.088

10.  Rapidly progressive neurodegenerative dementias.

Authors:  Keith A Josephs; J Eric Ahlskog; Joseph E Parisi; Bradley F Boeve; Brian A Crum; Caterina Giannini; Ronald C Petersen
Journal:  Arch Neurol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.